CBS Law

Arrangementer


Tidligere arrangementer

  • Seminar: What’s Law Got To Do With It: Integrating Law and Strategy

    25 maj, 2011 - 14:00 to 16:00
    Professor Bagley will present her work on developing a theory of law and strategy that embeds legal and other nonmarket factors in mainstream theories of competitive advantage. Professor Bagley will present her work on developing a theory of law and strategy that embeds legal and other nonmarket factors in mainstream theories of competitive advantage.

  • Brunch-seminar: Forstå den nye telelov

    9 maj, 2011 - 08:30 to 11:30
    Kromann Reumert og Juridisk Institut, CBS, inviterer til brunch-seminar omkring den nye telelov, der træder i kraft den 25. maj 2011

  • Seminar: Judicial Activism at the ECJ: An Empirical Assessment

    18 marts, 2011 - 12:30 to 14:00
    Senior Lecturer Iyiola Solanke, Leeds University Law school, will present a paper on the extent to which the European Court of Justice can still be considered a monolithic institution with ´runaway´ potential.

  • Seminar om Offentlig udbud og Offentlig-privat samarbejde mv.

    4 februar, 2011 - 13:00 to 16:00
    Indlæg på seminaret: Det norske klagesystem inden for offentlig udbud, det danske klagesystem med særlig henblik på den nye sanktion "uden virkning" ved direkte tildelte kontrakter, ordregivers muligheder for at ændre en kontrakt uden at være forpligtet til at afholde nyt udbud, OPS-strategi eller OPP-lov? og det danske klagesystem i nyt perspektiv.

  • Aflyst - Konference: Outsourcing i et forsikringsmæssigt perspektiv

    20 januar, 2011 - 12:50 to 17:00
    Konferencen holdes på et senere tidspunkt - Outsourcing indenfor forsikringsbranchen: Hvornår er det en fordel at outsource, og hvilke elementer skal man være særligt opmærksomme på.

  • Seminar: Abuse of a dominant market position

    20 januar, 2011 - 12:30 to 14:00
    In 2006 the EU Commission fined AstraZeneca €60 million for violating Article 82 of the EC Treaty for abusing pharmaceutical marketing authorization procedures and patent systems in seven Member States in order to prevent or delay entry by generic drug manufacturers. AstraZeneca was found to have engaged in behaviors sometimes called the “evergreening” of patents, by which companies control market access for both generic producers and for parallel traders.

  • Seminar: Do attitudes towards immigrants matter?

    9 februar, 2010 - 13:00 to 14:30
    Associate Professor Birthe Larsen, Department of Economics - CBS, will present research on the consequences of negative attitudes towards immigrants' welfare based on regional variation in negative attitudes towards immigrants to Sweden.

Sider